Angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation - AACHEN

Description:

The goal of the trial was to evaluate the effect of treatment with the angiotensin II receptor blocker (ARB) candesartan cilexetil on intimal hyperplasia after coronary stent implantation.